Cargando…
Steroid induction of therapy-resistant cytokeratin-5-positive cells in estrogen receptor-positive breast cancer through a BCL6-dependent mechanism
Therapy resistance remains a major problem in estrogen receptor-α (ERα)-positive breast cancer. A subgroup of ERα-positive breast cancer is characterized by mosaic presence of a minor population of ERα-negative cancer cells expressing the basal cytokeratin-5 (CK5). These CK5-positive cells are thera...
Autores principales: | Goodman, C R, Sato, T, Peck, A R, Girondo, M A, Yang, N, Liu, C, Yanac, A F, Kovatich, A J, Hooke, J A, Shriver, C D, Mitchell, E P, Hyslop, T, Rui, H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4800289/ https://www.ncbi.nlm.nih.gov/pubmed/26096934 http://dx.doi.org/10.1038/onc.2015.193 |
Ejemplares similares
-
Prolactin suppresses a progestin-induced CK5-positive cell population in luminal breast cancer through inhibition of progestin-driven BCL6 expression
por: Sato, Takahiro, et al.
Publicado: (2013) -
Prolactin-Stat5 signaling in breast cancer is potently disrupted by acidosis within the tumor microenvironment
por: Yang, Ning, et al.
Publicado: (2013) -
Validation of tumor protein marker quantification by two independent automated immunofluorescence image analysis platforms
por: Peck, Amy R, et al.
Publicado: (2016) -
High PD-L2 Predicts Early Recurrence of ER-Positive Breast Cancer
por: Chervoneva, Inna, et al.
Publicado: (2023) -
Spatial Metrics of Interaction between CD163-Positive Macrophages and Cancer Cells and Progression-Free Survival in Chemo-Treated Breast Cancer
por: Maisel, Brenton A., et al.
Publicado: (2022)